Ute Klinkhardt

Ute Klinkhardt is an experienced professional in the field of clinical development, specializing in oncology and immunotherapy. With a Doctor of Medicine (MD) and a PhD in Virology from the University Hospital Frankfurt, Klinkhardt has held several prominent roles, including Senior Global Clinical Program Lead at Boehringer Ingelheim, Chief Medical Officer at Speransa Therapeutics, and Senior Director of Clinical Development at BioNTech SE. Klinkhardt's expertise encompasses vaccine candidate development, immune modulation, and early clinical programs, further demonstrated through leadership positions at Merck KGaA and CureVac AG. Throughout a diverse career, Klinkhardt has contributed significantly to advancements in cell and gene therapy, TCR-T candidate development, and ORFV-based vaccines.